Bengt Westermark

Bengt Westermark

Directeur/Bestuurslid bij MEDIVIR AB
81 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Bengt Westermark is the founder of Mesenkia Therapeutics AB, serving as Chairman since 2023.
Current jobs include Independent Director at Medivir AB since 2017, Member of the Royal Swedish Academy of Sciences, Professor at the University of Uppsala since 2002, Member of the European Molecular Biology Organization, Member of the Royal Society of Sciences, and Member of The European Academy of Cancer Sciences.
Former jobs include Chairman-Research Board at The Swedish Cancer Society from 2003 to 2013, Independent Director at Medivir AB from 2017 to 2021, and Director at Hamlet BioPharma AB.

Actieve functies van Bengt Westermark

BedrijvenFunctieBegin
MEDIVIR AB Directeur/Bestuurslid 01-01-2017
Corporate Officer/Principal 01-01-1986
Corporate Officer/Principal -
European Molecular Biology Organization
Corporate Officer/Principal -
Royal Society of Sciences
Corporate Officer/Principal -
Corporate Officer/Principal -

Eerdere bekende functies van Bengt Westermark

BedrijvenFunctieEinde
MEDIVIR AB Directeur/Bestuurslid 05-05-2021
The Swedish Cancer Society
Corporate Officer/Principal 01-01-2013
HAMLET PHARMA AB (PUBL) Directeur/Bestuurslid -
Ervaring van Bengt Westermark in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

81

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit8

Health Technology

Commercial Services

Consumer Services

The Swedish Cancer Society

European Molecular Biology Organization

Health Technology

Royal Society of Sciences

Commercial Services

  1. Beurs
  2. Insiders
  3. Bengt Westermark